Caspase substrates and cellular remodeling

Annual Review of Biochemistry

Volumn 80, Issue , 2011, Pages 1055-1087

  Crawford, Emily D ^a   Wells, James A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

apoptosis; biomarkers; degradomics; differentiation; erythropoiesis; proteasome

Indexed keywords

ABELSON KINASE; CASPASE; CASPASE 10; CASPASE 12; CASPASE 14; CASPASE 2; CASPASE 3; CASPASE 4; CASPASE 5; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; INHIBITOR OF APOPTOSIS PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEASOME; TRANSCRIPTION FACTOR GATA 1; UBIQUITIN; X LINKED INHIBITOR OF APOPTOSIS;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CAENORHABDITIS ELEGANS; CELL DIFFERENTIATION; CELL NUCLEUS MEMBRANE; DROSOPHILA; ENRICHMENT CULTURE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LOCALIZATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; ERYTHROPOIESIS; GAIN OF FUNCTION MUTATION; GEL ELECTROPHORESIS; HIGH THROUGHPUT SCREENING; HUMAN; INTERMETHOD COMPARISON; INTRACELLULAR SIGNALING; LIQUID CHROMATOGRAPHY; LOSS OF FUNCTION MUTATION; MAMMAL; MASS SPECTROMETRY; METAZOON; MOLECULAR RECOGNITION; NONHUMAN; PLANT; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN QUATERNARY STRUCTURE; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; PROTEOMICS;

ANIMALS; APOPTOSIS; CASPASES; CELL DIFFERENTIATION; DIMERIZATION; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MODELS, MOLECULAR; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY;

METAZOA;

EID: 79959461070     PISSN: 00664154     EISSN: 00664154     Source Type: Book Series    
DOI: 10.1146/annurev-biochem-061809-121639     Document Type: Article

References (200)

1. Arama E, Agapite J, Steller H. 2003. Caspase activity and a specific cytochrome c are required for sperm differentiation in Drosophila. Dev. Cell 4:687-697. (Pubitemid 36564899)
2. Sordet O, Ŕeb́e C, Plenchette S, Zermati Y, Hermine O, et al. 2002. Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood 100:4446-453. (Pubitemid 35429684)
3. Lippens S, Denecker G, Ovaere P, Vandenabeele P, DeclercqW. 2005. Death penalty for keratinocytes: apoptosis versus cornification. Cell Death Differ. 12(Suppl. 2):1497-508. (Pubitemid 41553986)
4. Fernando P, Kelly JF, Balazsi K, Slack RS, Megeney LA. 2002. Caspase 3 activity is required for skeletal muscle differentiation. Proc. Natl. Acad. Sci. USA 99:11025-030. (Pubitemid 34920873)
5. Carlile GW, Smith DH, Wiedmann M. 2004. Caspase-3 has a nonapoptotic function in erythroid maturation. Blood 103:4310-316. (Pubitemid 38685378)
6. Khan AR, James MN. 1998. Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes. Protein Sci. 7:815-836. (Pubitemid 28216525)
7. Boatright KM, Salvesen GS. 2003. Mechanisms of caspase activation. Curr. Opin. Cell Biol. 15:725-731. (Pubitemid 37492933)
8. Schechter I, Berger A. 1967. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27:157-162.
9. Fuentes-Prior P, Salvesen GS. 2004. The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem. J. 384:201-232. (Pubitemid 39656233)
10. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, et al. 1997. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272:17907-911. (Pubitemid 27306365)
11. LamkanfiM, DeclercqW, Kalai M, Saelens X, Vandenabeele P. 2002. Alice in caspase land. A phylogenetic analysis of caspases from worm to man. Cell Death Differ. 9:358-361. (Pubitemid 34814616)
12. Launay S, Hermine O, Fontenay M, Kroemer G, Solary E, Garrido C. 2005. Vital functions for lethal caspases. Oncogene 24:5137-148. (Pubitemid 41192431)
13. Feinstein-Rotkopf Y, Arama E. 2009. Can't live without them, can live with them: roles of caspases during vital cellular processes. Apoptosis 14:980-995.
14. Yi CH, Yuan J. 2009. The Jekyll and Hyde functions of caspases. Dev. Cell 16:21-34.
15. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, et al. 1992. A novel heterodimeric cysteine protease is required for interleukin- 1βprocessing in monocytes. Nature 356:768-774.
16. Martinon F, Tschopp J. 2004. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117:561-574. (Pubitemid 38692523)
17. LamkanfiM, KannegantiT-D, VanDammeP, VandenBergheT, Vanoverberghe I, et al. 2008. Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes. Mol. Cell. Proteomics 7:2350-363.
18. Agard NJ, Maltby D, Wells JA. 2010. Inflammatory stimuli regulate caspase substrate profiles. Mol. Cell. Proteomics 9:880-893.
19. Van de Craen M, Van Loo G, Pype S, Van CriekingeW, Van Den Brande I, et al. 1998. Identification of a new caspase homologue: caspase-14. Cell Death Differ. 5:838-846. (Pubitemid 28484394)
20. Chien AJ, Presland RB, Kuechle MK. 2002. Processing of native caspase-14 occurs at an atypical cleavage site in normal epidermal differentiation. Biochem. Biophys. Res. Commun. 296:911-917.
21. Denecker G, Ovaere P, Vandenabeele P, DeclercqW. 2008. Caspase-14 reveals its secrets. J. Cell Biol. 180:451-458. (Pubitemid 351240694)
22. Denecker G, Hoste E, Gilbert B, Hochepied T, Ovaere P, et al. 2007. Caspase-14 protects against epidermal UVB photodamage and water loss. Nat. Cell Biol. 9:666-674. (Pubitemid 47214729)
23. Koenig U, Eckhart L, Tschachler E. 2001. Evidence that caspase-13 is not a human but a bovine gene. Biochem. Biophys. Res. Commun. 285:1150-154. (Pubitemid 32912900)
24. Eckhart L, Ballaun C, Uthman A, Kittel C, StichenwirthM, et al. 2005. Identification and characterization of a novel mammalian caspase with proapoptotic activity. J. Biol. Chem. 280:35077-080. (Pubitemid 41532692)
25. Eckhart L, Ballaun C, Hermann M, VandeBerg JL, Sipos W, et al. 2008. Identification of novel mammalian caspases reveals an important role of gene loss in shaping the human caspase repertoire. Mol. Biol. Evol. 25:831-841.
26. Ĺopez-Otín C, Overall CM. 2002. Protease degradomics: a new challenge for proteomics. Nat. Rev. Mol. Cell Biol. 3:509-519. (Pubitemid 34733432)
27. Agard NJ, Wells JA. 2009. Methods for the proteomic identification of protease substrates. Curr. Opin. Chem. Biol. 13:503-9.
28. L̈uthi AU, Martin SJ. 2007. The CASBAH: a searchable database of caspase substrates. Cell Death Differ. 14:641-650. (Pubitemid 46444502)
29. Rawlings ND, Barrett AJ, Bateman A. 2010. MEROPS: the peptidase database. Nucleic Acids Res. 38:D227-233.
30. P̈orn-Ares MI, Samali A, Orrenius S. 1998. Cleavage of the calpain inhibitor, calpastatin, during apoptosis. Cell Death Differ. 5:1028-033. (Pubitemid 29008216)
31. Saelens X, Festjens N, Vande Walle L, van Gurp M, van Loo G, Vandenabeele P. 2004. Toxic proteins released from mitochondria in cell death. Oncogene 23:2861-874. (Pubitemid 38638848)
32. Schotte P, DeclercqW, Van Huffel S, Vandenabeele P, Beyaert R. 1999. Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett. 442:117-121. (Pubitemid 29065390)
33. Gerner C, Frohwein U, Gotzmann J, Bayer E, Gelbmann D, et al. 2000. The Fas-induced apoptosis analyzed by high throughput proteome analysis. J. Biol. Chem. 275:39018-026. (Pubitemid 32058914)
34. Thiede B, Dimmler C, Siejak F, Rudel T. 2001. Predominant identification of RNA-binding proteins in Fas-induced apoptosis by proteome analysis. J. Biol. Chem. 276:26044-050.
35. Thiede B, Siejak F, Dimmler C, RudelT. 2002. Prediction of translocation and cleavage of heterogeneous ribonuclear proteins and Rho guanine nucleotide dissociation inhibitor 2 during apoptosis by subcellular proteome analysis. Proteomics 2:996-1006.
36. Gerner C, Gotzmann J, Fr̈ohwein U, SchambergerC, Ellinger A, Sauermann G. 2002. Proteome analysis of nuclear matrix proteins during apoptotic chromatin condensation. Cell Death Differ. 9:671-681. (Pubitemid 34618873)
37. Brockstedt E, Rickers A, Kostka S, Laubersheimer A, D̈orken B, et al. 1998. Identification of apoptosisassociated proteins in a human Burkitt lymphoma cell line. Cleavage of heterogeneous nuclear ribonucleoprotein A1 by caspase 3. J. Biol. Chem. 273:28057-064. (Pubitemid 28496099)
38. Lee AY, Park BC, Jang M, Cho S, Lee DH, et al. 2004. Identification of caspase-3 degradome by twodimensional gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics 4:3429-436. (Pubitemid 39525292)
39. Jang M, Park BC, Kang S, Lee D, ChoS, Lee SC. 2008. Mining of caspase-7 substrates using a degradomic approach. Mol. Cells 26:152-157.
40. Taylor RC, Brumatti G, Ito S, HengartnerMO, Derry WB, Martin SJ. 2007. Establishing a blueprint for CED-3-dependent killing through identification of multiple substrates for this protease. J. Biol. Chem. 282:15011-021. (Pubitemid 47093383)
41. Gygi SP, Corthals GL, Zhang Y, Rochon Y, Aebersold R. 2000. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc. Natl. Acad. Sci. USA 97:9390-395. (Pubitemid 30650785)
42. DixMM, SimonGM, Cravatt BF. 2008. Globalmapping of the topography andmagnitude of proteolytic events in apoptosis. Cell 134:679-691.
43. Brown JL, Roberts WK. 1976. Evidence that approximately eighty per cent of the soluble proteins from Ehrlich ascites cells are Nα-acetylated. J. Biol. Chem. 251:1009-014.
44. Van Damme P, Martens L, Van Damme J, Hugelier K, Staes A, et al. 2005. Caspase-specific and nonspecific in vivo protein processing during Fas-induced apoptosis. Nat. Methods 2:771-777. (Pubitemid 41486209)
45. Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, et al. 2003. Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat. Biotechnol. 21:566-569. (Pubitemid 36532024)
46. Demon D, Van Damme P, Vanden Berghe T, Deceuninck A, Van Durme J, et al. 2009. Proteome-wide substrate analysis indicates substrate exclusion as a mechanism to generate caspase-7 versus caspase-3 specificity. Mol. Cell. Proteomics 8:2700-714.
47. Impens F, Colaert N, Helsens K, Ghesquìere B, Timmerman E, et al. 2010. A quantitative proteomics design for systematic identification of protease cleavage events. Mol. Cell. Proteomics 9:2327-333.
48. Abrahmśen L, Tom J, Burnier J, Butcher KA, Kossiakoff A, Wells JA. 1991. Engineering subtilisin and its substrates for efficient ligation of peptide bonds in aqueous solution. Biochemistry 30:4151-159.
49. Jackson DY, Burnier J, Quan C, Stanley M, Tom J, Wells JA. 1994. A designed peptide ligase for total synthesis of ribonuclease A with unnatural catalytic residues. Science 266:243-247. (Pubitemid 24343508)
50. Chang TK, Jackson DY, Burnier JP, Wells JA. 1994. Subtiligase: a tool for semisynthesis of proteins. Proc. Natl. Acad. Sci. USA 91:12544-548.
51. Mahrus S, Trinidad JC, Barkan DT, Sali A, Burlingame AL, Wells JA. 2008. Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini. Cell 134:866-876.
52. Timmer JC, EnokssonM, Wildfang E, ZhuW, Igarashi Y, et al. 2007. Profiling constitutive proteolytic events in vivo. Biochem. J. 407:41-48. (Pubitemid 47535579)
53. EnokssonM, Li J, IvancicMM, Timmer JC, Wildfang E, et al. 2007. Identification of proteolytic cleavage sites by quantitative proteomics. J. Proteome Res. 6:2850-858. (Pubitemid 47122379)
54. Xu G, Shin SB, Jaffrey SR. 2009. Global profiling of protease cleavage sites by chemoselective labeling of protein N-termini. Proc. Natl. Acad. Sci. USA 106:19310-315.
55. Enoksson M, Salvesen GS. 2008. Proteolytic needles in the cellular haystack. Nat. Chem. Biol. 4:651-652.
56. Simon GM, Dix MM, Cravatt BF. 2009. Comparative assessment of large-scale proteomic studies of apoptotic proteolysis. ACS Chem. Biol. 4:401-8.
57. Krippner-Heidenreich A, Talanian RV, Sekul R, Kraft R, Thole H, et al. 2001. Targeting of the transcription factor Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1. Biochem. J. 358:705-715. (Pubitemid 32896958)
58. Hawkins CJ, Yoo SJ, Peterson EP, Wang SL. 2000. The Drosophila caspase DRONC cleaves following glutamate or aspartate and is regulated by DIAP1, HID, and GRIM. J. Biol. 275:27084-093.
59. Snipas SJ, Drag M, Stennicke HR, Salvesen GS. 2008. Activation mechanism and substrate specificity of the Drosophila initiator caspase DRONC. Cell Death Differ. 15:938-945. (Pubitemid 351524435)
60. Dorstyn L, Kumar S. 2008. A biochemical analysis of the activation of the Drosophila caspase DRONC. Cell Death Differ. 15:461-470. (Pubitemid 351267297)
61. Muro I, Means JC, Clem RJ. 2005. Cleavage of the apoptosis inhibitor DIAP1 by the apical caspase DRONC in both normal and apoptotic Drosophila cells. J. Biol. Chem. 280:18683-688. (Pubitemid 41379568)
62. Mikolajczyk J, Scott FL, Krajewski S, Sutherlin DP, Salvesen GS. 2004. Activation and substrate specificity of caspase-14. Biochemistry 43:10560-569. (Pubitemid 39079326)
63. Song Z, Guan B, Bergman A, Nicholson DW, Thornberry NA, et al. 2000. Biochemical and genetic interactions between Drosophila caspases and the proapoptotic genes rpr, hid, and grim. Mol. Cell. Biol. 20:2907-914. (Pubitemid 30183510)
64. Crooks GE, Hon G, Chandonia J-M, Brenner SE. 2004. WebLogo: a sequence logo generator. Genome Res. 14:1188-190. (Pubitemid 38811555)
65. Stennicke HR, Renatus M, Meldal M, Salvesen GS. 2000. Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8. Biochem. J. 350(Pt. 2):563-68.
66. Backes C, Kuentzer J, Lenhof HP, Comtesse N, Meese E. 2005. GraBCas: a bioinformatics tool for score-based prediction of caspase-and granzyme B-cleavage sites in protein sequences. Nucleic Acids Res. 33:W208-213. (Pubitemid 44529910)
67. Schilling O, Overall C. 2008. Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites. Nat. Biotechnol. 26:685-694. (Pubitemid 351809596)
68. Timmer JC, Zhu W, Pop C, Regan T, Snipas SJ, et al. 2009. Structural and kinetic determinants of protease substrates. Nat. Struct. Mol. Biol. 16:1101-8.
69. McStay GP, Salvesen GS, Green DR. 2008. Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways. Cell Death Differ. 15:322-331.
70. Fluhrer R, Friedlein A, Haass C, Walter J. 2004. Phosphorylation of presenilin 1 at the caspase recognition site regulates its proteolytic processing and the progression of apoptosis. J. Biol. Chem. 279:1585-593. (Pubitemid 38084422)
71. Walter J, Schindzielorz A, Gr̈unberg J, Haass C. 1999. Phosphorylation of presenilin-2 regulates its cleavage by caspases and retards progression of apoptosis. Proc. Natl. Acad. Sci. USA 96:1391-396. (Pubitemid 29098461)
72. Barkett M, Xue D, Horvitz HR, Gilmore TD. 1997. Phosphorylation of IkappaB-alpha inhibits its cleavage by caspase CPP32 in vitro. J. Biol. Chem. 272:29419-422. (Pubitemid 27508021)
73. Schweigreiter R, Stasyk T, Contarini I, Frauscher S, Oertle T, et al. 2007. Phosphorylation-regulated cleavage of the reticulon protein Nogo-B by caspase-7 at a noncanonical recognition site. Proteomics 7:4457-467.
74. Talanian RV, Quinlan C, Trautz S, Hackett MC, Mankovich JA, et al. 1997. Substrate specificities of caspase family proteases. J. Biol. Chem. 272:9677-682. (Pubitemid 27171628)
75. Benkova B, Lozanov V, Ivanov IP, Mitev V. 2009. Evaluation of recombinant caspase specificity by competitive substrates. Anal. Biochem. 394:68-74.
76. Fu G, Chumanevich AA, Agniswamy J, Fang B, Harrison RW, Weber IT. 2008. Structural basis for executioner caspase recognition of P5 position in substrates. Apoptosis 13:1291-302.
77. Fang B, Boross PI, Tozser J, Weber IT. 2006. Structural and kinetic analysis of caspase-3 reveals role for S5 binding site in substrate recognition. J. Mol. Biol. 360:654-666. (Pubitemid 43975116)
78. Fontana A, de Laureto PP, Spolaore B, Frare E, Picotti P, Zambonin M. 2004. Probing protein structure by limited proteolysis. Acta Biochim. Pol. 51:299-321. (Pubitemid 38969296)
79. Park C, Marqusee S. 2004. Probing the high energy states in proteins by proteolysis. J. Mol. Biol. 343:1467-476. (Pubitemid 39387837)
80. Kossiakoff A. 1985. The application of neutron crystallography to the study of dynamic and hydration properties of proteins. Annu. Rev. Biochem. 54:1195-227.
81. Garay-Malpartida HM, Occhiucci JM, Alves J, Beliźario JE. 2005. CaSPredictor: a new computer-based tool for caspase substrate prediction. Bioinformatics 21:i169-176. (Pubitemid 41794487)
82. Wee LJ, Tan TW, Ranganathan S. 2006. SVM-based prediction of caspase substrate cleavage sites.BMC Bioinform. 7(Suppl. 5):S14.
83. Barkan DT, Hostetter DR, Mahrus S, Pieper U, Wells JA, et al. 2010. Prediction of protease substrates using sequence and structure features. Bioinformatics 26:1714-722.
84. Xu G, Cirilli M, Huang Y, Rich RL, Myszka DG, Wu H. 2001. Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex. Nature 410:494-497. (Pubitemid 32240052)
85. Timmer JC, Salvesen GS. 2007. Caspase substrates. Cell Death Differ. 14:66-72. (Pubitemid 44911895)
86. Overall CM. 2002. Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites. Mol. Biotechnol. 22:51-86.
87. Krishnaswamy S. 2005. Exosite-driven substrate specificity and function in coagulation. J. Thromb. Haemost. 3:54-67. (Pubitemid 41647115)
88. Doucet A, Butler GS, Rodríguez D, Prudova A, Overall CM. 2008. Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome. Mol. Cell. Proteomics 7:1925-951.
89. Germain M, Affar EB, D'AmoursD, DixitVM, Salvesen GS, PoirierGG.1999. Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7. J. Biol. Chem. 274:28379-384.
90. Wolan DW, Zorn JA, Gray DC, Wells JA. 2009. Small-molecule activators of a proenzyme. Science 326:853-858.
91. Widlak P, Garrard WT. 2005. Discovery, regulation, and action of the major apoptotic nucleases DFF40/CAD and endonuclease G. J. Cell Biochem. 94:1078-087. (Pubitemid 41420231)
92. Nakagawa A, Shi Y, Kage-Nakadai E, Mitani S, Xue D. 2010. Caspase-dependent conversion of Dicer ribonuclease into a death-promoting deoxyribonuclease. Science 328:327-334.
93. Kurokawa M, Kornbluth S. 2009. Caspases and kinases in a death grip. Cell 138:838-854.
94. Ameisen JC. 2002. On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Differ. 9:367-393. (Pubitemid 34822817)
95. Chowdhury I, Tharakan B, Bhat GK. 2008. Caspases-an update. Comp. Biochem. Physiol. B 151:10-27.
96. Creagh EM, Brumatti G, SheridanC, Duriez PJ, Taylor RC, et al. 2009. Bicaudal is a conserved substrate for Drosophila and mammalian caspases and is essential for cell survival. PLoS One 4:e5055.
97. Valencia CA, Bailey C, Liu R. 2007. Novel zebrafish caspase-3 substrates. Biochem. Biophys. Res. Commun. 361:311-316. (Pubitemid 47187260)
98. Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, et al. 2004. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 429:75-79. (Pubitemid 38620553)
99. Mollereau B. 2009. Cell death: What can we learn from flies? Editorial for the special review issue on Drosophila apoptosis. Apoptosis 14:929-934.
100. Cooper DM, Granville DJ, Lowenberger C. 2009. The insect caspases. Apoptosis 14:247-256.
101. Mukae N, Yokoyama H, Yokokura T, Sakoyama Y, Sakahira H, Nagata S. 2000. Identification and developmental expression of inhibitor of caspase-activated DNase (ICAD) in Drosophila melanogaster. J. Biol. Chem. 275:21402-8. (Pubitemid 30481841)
102. Yokoyama H, Mukae N, Sakahira H, Okawa K, Iwamatsu A, Nagata S. 2000. A novel activation mechanism of caspase-activated DNase from Drosophila melanogaster. J. Biol. Chem. 275:12978-986. (Pubitemid 30241456)
103. Amarneh B, Matthews KA, Rawson RB. 2009. Activation of sterol regulatory element-binding protein by the caspase Drice in Drosophila larvae. J. Biol. Chem. 284:9674-682.
104. Wang X, Pai JT, Wiedenfeld EA, Medina JC, Slaughter CA, et al. 1995. Purification of an interleukin-1 beta converting enzyme-related cysteine protease that cleaves sterol regulatory element-binding proteins between the leucine zipper and transmembrane domains. J. Biol. Chem. 270:18044-050.
105. Higgins ME, Ioannou YA. 2001. Apoptosis-induced release ofmature sterol regulatory element-binding proteins activates sterol-responsive genes. J. Lipid. Res. 42:1939-946. (Pubitemid 34001042)
106. Ellis HM, Horvitz HR. 1986. Genetic control of programmed cell death in the nematode C. elegans. Cell 44:817-829. (Pubitemid 16045328)
107. Westein SJ, Scott FL, Hawkins CJ. 2008. Analysis of the minimal specificity of CED-3 using a yeast transcriptional reporter system. Biochim. Biophys. Acta 1783:448-454. (Pubitemid 351232061)
108. Uren AG, O'Rourke K, Aravind LA, Pisabarro MT, Seshagiri S, et al. 2000. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol. Cell 6:961-967.
109. Vercammen D, Declercq W, Vandenabeele P, Van Breusegem F. 2007. Are metacaspases caspases? J. Cell Biol. 179:375-380. (Pubitemid 350074782)
110. Woltering EJ. 2010. Death proteases: alive and kicking. Trends Plant. Sci. 15:185-188.
111. V́achov́a L, Palkov́a Z. 2007. Caspases in yeast apoptosis-like death: facts and artefacts. FEMS Yeast Res. 7:12-21. (Pubitemid 46122026)
112. van Doorn WG, Woltering EJ. 2005. Many ways to exit? Cell death categories in plants. Trends Plant Sci. 10:117-122. (Pubitemid 40323295)
113. Vercammen D, van de Cotte B, De Jaeger G, Eeckhout D, Casteels P, et al. 2004. Type II metacaspases Atmc4 and Atmc9 of Arabidopsis thaliana cleave substrates after arginine and lysine. J. Biol. Chem. 279:45329-336. (Pubitemid 39491515)
114. Chichkova NV, Kim SH, Titova ES, Kalkum M, Morozov VS, et al. 2004. A plant caspase-like protease activated during the hypersensitive response. Plant Cell 16:157-171. (Pubitemid 38162360)
115. Reavy B, Bagirova S, Chichkova NV, Fedoseeva SV, Kim SH, et al. 2007. Caspase-resistant VirD2 protein provides enhanced gene delivery and expression in plants. Plant Cell Rep. 26:1215-219. (Pubitemid 47124991)
116. Sundstr̈om JF, Vaculova A, Smertenko AP, Savenkov EI, Golovko A, et al. 2009. Tudor staphylococcal nuclease is an evolutionarily conserved component of the programmed cell death degradome. Nat. Cell Biol. 11:1347-354.
117. Mazzoni C, Falcone C. 2008. Caspase-dependent apoptosis in yeast. Biochim. Biophys. Acta 1783:1320-327.
118. Gray DC, Mahrus S, Wells JA. 2010. Activation of specific apoptotic caspases with an engineered smallmolecule- activated protease. Cell 142:637-646.
119. Albeck JG, Burke JM, Aldridge BB, ZhangM, Lauffenburger DA, Sorger PK. 2008. Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. Mol. Cell 30:11-25. (Pubitemid 351470145)
120. Spencer SL, Gaudet S, Albeck JG, Burke JM, Sorger PK. 2009. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 459:428-432.
121. Van de CraenM, DeclercqW. 1999. The proteolytic procaspase activation network: an in vitro analysis. Cell Death Differ. 6:1117-124.
122. BaderM, Steller H. 2009. Regulation of cell death by the ubiquitin-proteasome system. Curr. Opin. Cell Biol. 21:878-884.
123. Eckelman BP, Salvesen GS, Scott FL. 2006. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 7:988-994. (Pubitemid 44480512)
124. Suzuki Y, Nakabayashi Y, Takahashi R. 2001. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc. Natl. Acad. Sci. USA 98:8662-667. (Pubitemid 32678084)
125. Wilson R, Goyal L, Ditzel M, Zachariou A, Baker DA, et al. 2002. The DIAP1 RING finger mediates ubiquitination of Dronc and is indispensable for regulating apoptosis. Nat. Cell Biol. 4:445-450. (Pubitemid 34746163)
126. Schile AJ, García-Ferńandez M, Steller H. 2008. Regulation of apoptosis by XIAP ubiquitin-ligase activity. Genes Dev. 22:2256-266.
127. Ditzel M, BroemerM, Tenev T, Bolduc C, Lee TV, et al. 2008. Inactivation of effector caspases through nondegradative polyubiquitylation. Mol. Cell 32:540-553.
128. Arama E, Agapite J, Steller H. 2003. Caspase activity and a specific cytochrome c are required for sperm differentiation in Drosophila. Dev. Cell 4:687-697. (Pubitemid 36564899)
129. Vaux DL, Silke J. 2005. IAPs, RINGs and ubiquitylation. Nat. Rev. Mol. Cell Biol. 6:287-297. (Pubitemid 40516895)
130. Broemer M, Meier P. 2009. Ubiquitin-mediated regulation of apoptosis. Trends Cell Biol. 19:130-140.
131. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC. 1999. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J. 18:5242-251. (Pubitemid 29465575)
132. Clem RJ, Sheu TT, Richter BW, He WW, Thornberry NA, et al. 2001. c-IAP1 is cleaved by caspases to produce a proapoptotic C-terminal fragment. J. Biol. Chem. 276:7602-8.
133. Bartke T, Pohl C, Pyrowolakis G, Jentsch S. 2004. Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3 ubiquitin ligase. Mol. Cell 14:801-811. (Pubitemid 38780853)
134. Ditzel M, Wilson R, Tenev T, Zachariou A, Paul A, et al. 2003. Degradation of DIAP1 by the N-end rule pathway is essential for regulating apoptosis. Nat. Cell Biol. 5:467-473. (Pubitemid 36592271)
135. Herman-BachinskyY, Ryoo H-D, Ciechanover A, GonenH. 2007. Regulation of the Drosophila ubiquitin ligase DIAP1 is mediated via several distinct ubiquitin system pathways. Cell Death Differ. 14:861-871. (Pubitemid 46444523)
136. Srinivasula SM, Hegde R, Saleh A, Datta P, Shiozaki E, et al. 2001. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 410:112-116. (Pubitemid 32225846)
137. Chen DJ, Huerta S. 2009. Smac mimetics as new cancer therapeutics. Anti-Cancer Drugs 20:646-658.
138. Hell K, Saleh M, Crescenzo GD, O'Connor-McCourt MD, Nicholson DW. 2003. Substrate cleavage by caspases generates protein fragments with Smac/Diablo-like activities. Cell Death Differ. 10:1234-239. (Pubitemid 37407125)
139. Gallastegui N, Groll M. 2010. The 26S proteasome: assembly and function of a destructive machine. Trends Biochem. Sci. 35:634-642.
140. Baumeister W, Walz J, Z̈uhl F, Seem̈uller E. 1998. The proteasome: paradigm review of a selfcompartmentalizing protease. Cell 92:367-390.
141. Deng XW, Dubiel W, Wei N, Hofmann K, Mundt K, et al. 2000. Unified nomenclature for the COP9 signalosome and its subunits: an essential regulator of development. Trends Genet. 16:202-3. (Pubitemid 30216544)
142. Sun XM, Butterworth M, MacFarlane M, Dubiel W, Ciechanover A, Cohen GM. 2004. Caspase activation inhibits proteasome function during apoptosis. Mol. Cell 14:81-93. (Pubitemid 38469911)
143. Wang XH, Zhang L, Mitch WE, LeDoux JM, Hu J, Du J. 2010. Caspase-3 cleaves specific 19 S proteasome subunits in skeletal muscle stimulating proteasome activity. J. Biol. Chem. 285:21249-257.
144. Adrain C, Creagh EM, Cullen SP, Martin SJ. 2004. Caspase-dependent inactivation of proteasome function during programmed cell death in Drosophila and man. J. Biol. Chem. 279:36923-930. (Pubitemid 39129042)
145. Jang M, Park BC, Lee AY, Na KS, Kang S, et al. 2007. Caspase-7 mediated cleavage of proteasome subunits during apoptosis. Biochem. Biophys. Res. Commun. 363:388-394. (Pubitemid 47484343)
146. Thiede B, Treumann A, Kretschmer A, S̈ohlke J, Rudel T. 2005. Shotgun proteome analysis of protein cleavage in apoptotic cells. Proteomics 5:2123-130. (Pubitemid 40770576)
147. Araya R, Takahashi R, Nomura Y. 2002. Yeast two-hybrid screening using constitutive-active caspase-7 as bait in the identification of PA28gamma as an effector caspase substrate. Cell Death Differ. 9:322-328. (Pubitemid 34223875)
148. Shah JJ, Orlowski RZ. 2009. Proteasome inhibitors in the treatment of multiple myeloma. Leukemia 23:1964-979.
149. Wang JY. 2000. Regulation of cell death by the Abl tyrosine kinase. Oncogene 19:5643-650.
150. Wen ST, Jackson PK, Van Etten RA. 1996. The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products. EMBO J. 15:1583-595. (Pubitemid 26112380)
151. Taagepera S, McDonald D, Loeb JE, Whitaker LL, McElroy AK, et al. 1998. Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase. Proc. Natl. Acad. Sci. USA 95:7457-462. (Pubitemid 28293274)
152. Baril̀a D, Rufini A, Cond̀o I, Ventura N, Dorey K, et al. 2003. Caspase-dependent cleavage of c-Abl contributes to apoptosis. Mol. Cell. Biol. 23:2790-799. (Pubitemid 36403078)
153. Machuy N, Rajalingam K, Rudel T. 2004. Requirement of caspase-mediated cleavage of c-Abl during stress-induced apoptosis. Cell Death Differ. 11:290-300. (Pubitemid 38313138)
154. J̈anicke RU, Walker PA, Lin XY, Porter AG. 1996. Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J. 15:6969-978. (Pubitemid 27023268)
155. Fattman CL, Delach SM, Dou QP, Johnson DE. 2001. Sequential two-step cleavage of the retinoblastoma protein by caspase-3/-7 during etoposide-induced apoptosis. Oncogene 20:2918-926. (Pubitemid 33027759)
156. Tan X, Wang JY. 1998. The caspase-RB connection in cell death. Trends Cell Biol. 8:116-120. (Pubitemid 28077736)
157. Raina D, Pandey P, Ahmad R, Bharti A, Ren J, et al. 2005. c-Abl tyrosine kinase regulates caspase-9 autocleavage in the apoptotic response to DNA damage. J. Biol. Chem. 280:11147-151. (Pubitemid 40418421)
158. Yoshida K. 2008. Nuclear trafficking of pro-apoptotic kinases in response to DNA damage. Trends Mol. Med. 14:305-313.
159. Dixon AS, KakarM, Schneider KMH, Constance JE, Paullin BC, Lim CS. 2009. Controlling subcellular localization to alter function: Sending oncogenic Bcr-Abl to the nucleus causes apoptosis. J. Control. Release 140:245-249.
160. Vigneri P, Wang JY. 2001. Induction of apoptosis in chronicmyelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase. Nat. Med. 7:228-234. (Pubitemid 32148491)
161. Lane JD, Allan VJ, Woodman PG. 2005. Active relocation of chromatin and endoplasmic reticulum into blebs in late apoptotic cells. J. Cell Sci. 118:4059-071. (Pubitemid 41410287)
162. Croft DR, Coleman ML, Li S, Robertson D, Sullivan T, et al. 2005. Actin-myosin-based contraction is responsible for apoptotic nuclear disintegration. J. Cell Biol. 168:245-255. (Pubitemid 40248222)
163. Krauss SW, Lo AJ, Short SA, Koury MJ, Mohandas N, Chasis JA. 2005. Nuclear substructure reorganization during late-stage erythropoiesis is selective and does not involve caspase cleavage ofmajor nuclear substructural proteins. Blood 106:2200-5. (Pubitemid 41291741)
164. Rao L, Perez D, White E. 1996. Lamin proteolysis facilitates nuclear events during apoptosis. J. Cell Biol. 135:1441-455. (Pubitemid 26427643)
165. Orth K, Chinnaiyan AM, Garg M, Froelich CJ, Dixit VM. 1996. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J. Biol. Chem. 271:16443-446. (Pubitemid 26238991)
166. Fraser AG, McCarthy NJ, Evan GI. 1997. drICE is an essential caspase required for apoptotic activity in Drosophila cells. EMBO J. 16:6192-199. (Pubitemid 27458339)
167. Slee EA, Adrain C, Martin SJ. 2001. Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J. Biol. Chem. 276:7320-326.
168. Ruchaud S, Korfali N, Villa P, Kottke TJ, Dingwall C, et al. 2002. Caspase-6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation. EMBO J. 21:1967-977. (Pubitemid 34437194)
169. Inoue S, Browne G, Melino G, Cohen GM. 2009. Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway. Cell Death Differ. 16:1053-061.
170. Taylor RC, Cullen SP, Martin SJ. 2008. Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 9:231-241. (Pubitemid 351301823)
171. Seki M, Shirasawa H. 1965. Role of the reticular cells during maturation process of the erythroblast. 3. The fate of phagocytized nucleus. Acta Pathol. Jpn. 15:387-405.
172. Koury MJ, Bondurant MC. 1990. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248:378-381.
173. Gregoli PA, Bondurant MC. 1997. The roles of Bcl-X(L) and apopain in the control of erythropoiesis by erythropoietin. Blood 90:630-640. (Pubitemid 27299103)
174. Weiss MJ, Orkin SH. 1995. Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. Proc. Natl. Acad. Sci. USA 92:9623-627.
175. Zermati Y, Garrido C, Amsellem S, Fishelson S, Bouscary D, et al. 2001. Caspase activation is required for terminal erythroid differentiation. J. Exp. Med. 193:247-254. (Pubitemid 32524456)
176. Carlile GW, Smith DH, WiedmannM. 2009. A non-apoptotic role for Fas/FasL in erythropoiesis. FEBS Lett. 583:848-854.
177. Kolbus A, Pilat S, Husak Z, Deiner EM, Stengl G, et al. 2002. Raf-1 antagonizes erythroid differentiation by restraining caspase activation. J. Exp. Med. 196:1347-353. (Pubitemid 35375553)
178. Sztiller-Sikorska M, Jakubowska J, Wozniak M, Stasiak M, Czyz M. 2009. A non-apoptotic function of caspase-3 in pharmacologically-induced differentiation of K562 cells. Br. J. Pharmacol. 157:1451-462.
179. Carlile GW, Smith DH, Wiedmann M. 2004. Caspase-3 has a nonapoptotic function in erythroid maturation. Blood 103:4310-316. (Pubitemid 38685378)
180. De Maria R, Zeuner A, Eramo A, Domenichelli C, Bonci D, et al. 1999. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature 401:489-493.
181. Ribeil JA, Zermati Y, Vandekerckhove J, Cathelin S, Kersual J, et al. 2007. Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1. Nature 445:102-5. (Pubitemid 46067309)
182. Lanneau D, de Thonel A, Maurel S, Didelot C, Garrido C. 2007. Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27. Prion 1:53-60.
183. Tripic T, Deng W, Cheng Y, Zhang Y, Vakoc CR, et al. 2009. SCL and associated proteins distinguish active from repressive GATA transcription factor complexes. Blood 113:2191-201.
184. Zeuner A, Eramo A, Testa U, Felli N, Pelosi E, et al. 2003. Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1. Cell Death Differ. 10:905-913. (Pubitemid 36939701)
185. Putt KS, Chen GW, Pearson JM, Sandhorst JS, Hoagland MS, et al. 2006. Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy. Nat. Chem. Biol. 2:543-550. (Pubitemid 44413237)
186. Zorn JA, Wells JA. 2010. Turning enzymes ON with small molecules. Nat. Chem. Biol. 6:179-188.
187. Brown JM, Attardi LD. 2005. The role of apoptosis in cancer development and treatment response. Nat. Rev. Cancer 5:231-237. (Pubitemid 40314954)
188. Holdenrieder S, Stieber P, Bodenm̈uller H, Busch M, Fertig G, et al. 2001. Nucleosomes in serum of patients with benign and malignant diseases. Int. J. Cancer 95:114-120. (Pubitemid 32187083)
189. Caulín C, Salvesen GS, Oshima RG. 1997. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J. Cell Biol. 138:1379-394.
190. LeersMP, K̈olgenW, Bj̈orklundV, Bergman T, Tribbick G, et al. 1999. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J. Pathol. 187:567-572. (Pubitemid 29151999)
191. Ueno T, Toi M, Biv́en K, Bando H, Ogawa T, Linder S. 2003. Measurement of an apoptotic product in the sera of breast cancer patients. Eur. J. Cancer 39:769-774. (Pubitemid 36315993)
192. Olofsson MH, Ueno T, Pan Y, Xu R, Cai F, et al. 2007. Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy. Clin. Cancer Res. 13:3198-206. (Pubitemid 46944902)
193. Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Zhu Y, et al. 1999. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-βprecursor protein and amyloidogenic Aβpeptide formation. Cell 97:395-406.
194. Rohn TT, Rissman RA, Davis MC, Kim YE, Cotman CW, Head E. 2002. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Neurobiol. Dis. 11:341-354. (Pubitemid 36135697)
195. Guo H, Albrecht S, Bourdeau M, Petzke T, Bergeron C, LeBlanc AC. 2004. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease. Am. J. Pathol. 165:523-531. (Pubitemid 38971382)
196. Rohn TT, Head E, Su JH, Anderson AJ, Bahr BA, et al. 2001. Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease. Am. J. Pathol. 158:189-198. (Pubitemid 32096484)
197. Yang F, Sun X, BeechW, Teter B, WuS, et al. 1998. Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. Am. J. Pathol. 152:379-389. (Pubitemid 28106384)
198. Klaiman G, Petzke TL, Hammond J, Leblanc AC. 2008. Targets of caspase-6 activity in human neurons and Alzheimer disease. Mol. Cell. Proteomics 7:1541-555.
199. Sintiprungrat K, Singhto N, Sinchaikul S, Chen S-T, Thongboonkerd V. 2010. Alterations in cellular proteome and secretome upon differentiation from monocyte to macrophage by treatment with phorbol myristate acetate: insights into biological processes. J. Proteomics 73:602-618.
200. Shao W, Yeretssian G, Doiron K, Hussain SN, Saleh M. 2007. The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J. Biol. Chem. 282:36321-29